Omar Serna

432 total citations
31 papers, 312 citations indexed

About

Omar Serna is a scholar working on Family Practice, Geriatrics and Gerontology and Economics and Econometrics. According to data from OpenAlex, Omar Serna has authored 31 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Family Practice, 17 papers in Geriatrics and Gerontology and 13 papers in Economics and Econometrics. Recurrent topics in Omar Serna's work include Medication Adherence and Compliance (23 papers), Pharmaceutical Practices and Patient Outcomes (17 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Omar Serna is often cited by papers focused on Medication Adherence and Compliance (23 papers), Pharmaceutical Practices and Patient Outcomes (17 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Omar Serna collaborates with scholars based in United States, India and Ireland. Omar Serna's co-authors include Susan Abughosh, Ekere James Essien, Marc L. Fleming, Marcia McDonnell Holstad, Michael L. Johnson, Aisha Vadhariya, Rutugandha Paranjpe, Xin Wang, Susan Boklage and Xin Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and Patient Education and Counseling.

In The Last Decade

Omar Serna

29 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omar Serna United States 9 204 121 95 89 38 31 312
Irene Lizano‐Díez Spain 7 109 0.5× 55 0.5× 114 1.2× 68 0.8× 27 0.7× 19 276
Remon Helmy Switzerland 4 192 0.9× 70 0.6× 68 0.7× 59 0.7× 67 1.8× 5 309
Anping Chang United States 8 119 0.6× 74 0.6× 153 1.6× 50 0.6× 22 0.6× 15 303
Alfredo Dias de Oliveira‐Filho Brazil 9 175 0.9× 175 1.4× 129 1.4× 41 0.5× 44 1.2× 30 381
Susanne Jank Germany 8 188 0.9× 129 1.1× 55 0.6× 61 0.7× 59 1.6× 9 325
Kevin Townsend United States 10 78 0.4× 101 0.8× 112 1.2× 66 0.7× 19 0.5× 27 289
Jennifer Dotta-Celio Switzerland 6 219 1.1× 114 0.9× 33 0.3× 57 0.6× 90 2.4× 13 338
Łukasz Tanajewski United Kingdom 9 81 0.4× 113 0.9× 42 0.4× 85 1.0× 22 0.6× 19 323
Robert Prowse Australia 8 85 0.4× 278 2.3× 43 0.5× 153 1.7× 75 2.0× 11 382
Marcel Leppée Croatia 7 96 0.5× 52 0.4× 54 0.6× 36 0.4× 40 1.1× 22 261

Countries citing papers authored by Omar Serna

Since Specialization
Citations

This map shows the geographic impact of Omar Serna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar Serna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar Serna more than expected).

Fields of papers citing papers by Omar Serna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar Serna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar Serna. The network helps show where Omar Serna may publish in the future.

Co-authorship network of co-authors of Omar Serna

This figure shows the co-authorship network connecting the top 25 collaborators of Omar Serna. A scholar is included among the top collaborators of Omar Serna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar Serna. Omar Serna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serna, Omar, et al.. (2025). Driving pressure como parámetro integrador en ventilación mecánica: de la fisiología al reto clínico de la personalización. Acta Colombiana de Cuidado Intensivo. 25(4). 681–692.
2.
Johnson, Michael L., Ekere James Essien, Jamie C. Barner, et al.. (2023). A Motivational Interviewing Intervention to Improve Adherence to ACEIs/ARBs among Nonadherent Older Adults with Comorbid Hypertension and Diabetes. Drugs & Aging. 40(4). 377–390. 15 indexed citations
3.
Johnson, Michael L., Ekere James Essien, Jamie C. Barner, et al.. (2022). Patient-Reported Barriers to Adherence Among ACEI/ARB Users from a Motivational Interviewing Telephonic Intervention. Patient Preference and Adherence. Volume 16. 2739–2748. 2 indexed citations
4.
Paranjpe, Rutugandha, et al.. (2022). Adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments among older patients. Journal of the American Pharmacists Association. 62(4). 1351–1358. 4 indexed citations
5.
Paranjpe, Rutugandha, et al.. (2022). Evaluating Adherence to Concomitant Diabetes, Hypertension, and Hyperlipidemia Treatments and Cardiovascular Outcomes Among Elderly Patients Using Marginal Structural Modeling. High Blood Pressure & Cardiovascular Prevention. 29(6). 601–610. 1 indexed citations
6.
Vadhariya, Aisha, et al.. (2021). Impact of a motivational interviewing intervention targeting statins on adherence to concurrent hypertension or diabetes medications. Patient Education and Counseling. 104(7). 1756–1764. 6 indexed citations
7.
Vadhariya, Aisha, et al.. (2021). Evaluating perceptions of social determinants of health and Part D star performance of Medicare Advantage-contracted primary care providers serving a South Texas market. Journal of Managed Care & Specialty Pharmacy. 27(5). 544–553. 4 indexed citations
8.
Paranjpe, Rutugandha, Michael L. Johnson, Ekere James Essien, et al.. (2020). <p>Group-Based Trajectory Modeling to Identify Patterns of Adherence and Its Predictors Among Older Adults on Angiotensin-Converting Enzyme Inhibitors (ACEIs)/Angiotensin Receptor Blockers (ARBs)</p>. Patient Preference and Adherence. Volume 14. 1935–1947. 15 indexed citations
9.
Wang, Xin, Hua Chen, Ekere James Essien, et al.. (2020). Risk of Cardiovascular Outcomes and Antihypertensive Triple Combination Therapy Among Elderly Patients with Hypertension Enrolled in a Medicare Advantage Plan (MAP). American Journal of Cardiovascular Drugs. 20(6). 591–602. 5 indexed citations
10.
Chen, Hua, Ekere James Essien, Jun Wu, et al.. (2020). Cost-effectiveness analysis of antihypertensive triple combination therapy among patients enrolled in a Medicare advantage plan. Expert Review of Pharmacoeconomics & Outcomes Research. 21(4). 829–836. 8 indexed citations
11.
12.
Wang, Xin, Hua Chen, Ekere James Essien, et al.. (2019). Medication Adherence to Antihypertensive Triple-Combination Therapy Among Patients Enrolled in a Medicare Advantage Plan. Journal of Managed Care & Specialty Pharmacy. 25(6). 678–686. 18 indexed citations
13.
Vadhariya, Aisha, Marc L. Fleming, Michael L. Johnson, et al.. (2019). Group-Based Trajectory Models to Identify Sociodemographic and Clinical Predictors of Adherence Patterns to Statin Therapy Among Older Adults.. PubMed. 12(4). 202–211. 25 indexed citations
14.
Serna, Omar, et al.. (2018). Effectiveness of mailed letters to improve medication adherence among Medicare Advantage Plan participants with chronic conditions. Patient Preference and Adherence. Volume 13. 37–46. 5 indexed citations
15.
Abughosh, Susan, et al.. (2016). Evaluating Pharmacist-Written Recommendations to Providers in a Medicare Advantage Plan: Factors Associated with Provider Acceptance. Journal of Managed Care & Specialty Pharmacy. 22(1). 49–55. 14 indexed citations
16.
Mhatre, Shivani K., Omar Serna, Shubhada Sansgiry, et al.. (2016). Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool. Journal of Managed Care & Specialty Pharmacy. 22(11). 1293–1301. 4 indexed citations
17.
18.
19.
20.
Serna, Omar, et al.. (2013). Quality Compensation Programs: Are They Worth All the Hype? A Comparison of Outcomes Within a Medicare Advantage Heart Failure Population. Journal of Managed Care Pharmacy. 19(4). 317–324. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irene Lizano‐Díez Breakdown of academic impact, for papers by Remon Helmy Breakdown of academic impact, for papers by Anping Chang Breakdown of academic impact, for papers by Alfredo Dias de Oliveira‐Filho Breakdown of academic impact, for papers by Susanne Jank Breakdown of academic impact, for papers by Kevin Townsend Breakdown of academic impact, for papers by Jennifer Dotta-Celio Breakdown of academic impact, for papers by Łukasz Tanajewski Breakdown of academic impact, for papers by Robert Prowse Breakdown of academic impact, for papers by Marcel Leppée
Rankless by CCL
2026